Improving surveillance of tobacco products to protect public health
Official title: Rutgers Center of Excellence in Rapid Surveillance of Tobacco
Funded at Rutgers Biomedical and Health Sciences · NIH-11098505 · Data updated 2026-11-12
This study is looking at how people, especially young folks, use different tobacco products like e-cigarettes and cigars, so we can better understand their effects on health and help make informed rules to keep everyone safe.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | June 1, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $3,562,921 |
| NIH project number | 5U01CA278695-03 |
| Project ID | NIH-11098505 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include youth and adults who use or are at risk of using alternative tobacco products, such as e-cigarettes and cigars.
✕Less likely to help
Patients who do not use tobacco products or have no interest in tobacco cessation may not benefit from this research.
What this research studies
This research focuses on enhancing the surveillance systems for various tobacco products, including e-cigarettes and cigars, to better understand their usage patterns and health impacts. By establishing a collaborative network, the project aims to quickly assess changes in the tobacco market and inform regulatory actions by the FDA. The methodology involves collecting and analyzing data on tobacco product use, particularly among youth, to ensure timely responses to emerging trends. This initiative seeks to fill gaps in existing surveillance systems that have been slow to adapt to the evolving tobacco landscape.
Why it matters
Potential benefit: If successful, this research could lead to more effective regulations and public health strategies that reduce tobacco use and its associated health risks.
How similar studies have gone: Previous research has shown success in improving tobacco surveillance systems, but this approach aims to address novel challenges posed by the rapidly changing tobacco market.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Delnevo, Cristine D — Rutgers Biomedical and Health Sciences
- Study coordinator: Delnevo, Cristine D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.